Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors

by Bai, J., Batrakou, D.G, Boross-Harmer, S., Broad, R., Brophy, F., Butler, M.O, Dumbrava, E.E, Duose, D.Y, Fayngerts, S., Fracasso, P.M, Frigault, M.J, Gerry, A.B, Ghobadi, A., Hong, D.S, Kebriaei, P., Marks, D., Navenot, J.-M, Norry, E., Pachynski, R.K, Sanderson, J.P, Sauer, A., Solis, L.M, Sullivan, R., Wang, R., Wolchinsky, Z.
Published 2022